M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Processa Pharmaceuticals, Inc. to acquire Vidya Therapeutics
Announced Jul 29, 2026 · Closed Jul 29, 2026 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock
Transaction
- Acquirer
- Processa Pharmaceuticals, Inc. (PCSA)
- Target
- Vidya Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jul 29, 2026
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Tungsten Advisors
- To the target
- Leerink Partners
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations